InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by GUETH ANTON, Director. Officer active across 2 companies, notably Antares Pharma, INC.. Aggregated, 10 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €724k. History available since 29 April 2021. The latest transaction was filed on 24 May 2022 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
386,132 shares@ US$5.6063.4% of flowCommon StockSEC:0000899243-22-019796:0
100,000 shares@ US$4.2911.4% of flowCommon StockSEC:0001209191-21-046205
100,000 shares@ US$4.2911.4% of flowCommon StockSEC:0001209191-21-046205:0
25,452 shares@ US$4.422.9% of flowCommon StockSEC:0001209191-21-040333
25,452 shares@ US$4.422.9% of flowCommon StockSEC:0001209191-21-040333:0
40,000 sharesCommon StockSEC:0001209191-21-030644
40,000 shares@ US$1.661.7% of flowCommon StockSEC:0001209191-21-030644:0
72,669 shares@ US$1.663.1% of flowCommon StockSEC:0001209191-21-029595
72,669 shares@ US$1.663.1% of flowCommon StockSEC:0001209191-21-029595:0
16,918 sharesCommon StockSEC:0001144204-16-074940:0
10 of 10 declarations
About GUETH ANTON
GUETH ANTON is a Director at ANTARES PHARMA, INC. In this role, he participates in the governance of the company, ensuring compliance and transparency in operations. His experience in the pharmaceutical sector allows him to effectively contribute to strategic decision-making. Anton is committed to maximizing shareholder value.
